207 related articles for article (PubMed ID: 9388230)
21. Differentiation of lactotrope precursor GHFT cells in response to fibroblast growth factor-2.
López-Fernández J; Palacios D; Castillo AI; Tolon RM; Aranda A; Karin M
J Biol Chem; 2000 Jul; 275(28):21653-60. PubMed ID: 10801832
[TBL] [Abstract][Full Text] [Related]
22. Mesoderm induction in Xenopus caused by activation of MAP kinase.
Umbhauer M; Marshall CJ; Mason CS; Old RW; Smith JC
Nature; 1995 Jul; 376(6535):58-62. PubMed ID: 7541116
[TBL] [Abstract][Full Text] [Related]
23. Fibroblast growth factor-2 suppression of tumor necrosis factor alpha-mediated apoptosis requires Ras and the activation of mitogen-activated protein kinase.
Gardner AM; Johnson GL
J Biol Chem; 1996 Jun; 271(24):14560-6. PubMed ID: 8662985
[TBL] [Abstract][Full Text] [Related]
24. Stimulation of the P-450 side chain cleavage enzyme (CYP11A1) promoter through ras- and Ets-2-signaling pathways.
Pestell RG; Albanese C; Watanabe G; Lee RJ; Lastowiecki P; Zon L; Ostrowski M; Jameson JL
Mol Endocrinol; 1996 Sep; 10(9):1084-94. PubMed ID: 8885243
[TBL] [Abstract][Full Text] [Related]
25. junB promoter regulation: Ras mediated transactivation by c-Ets-1 and c-Ets-2.
Coffer P; de Jonge M; Mettouchi A; Binetruy B; Ghysdael J; Kruijer W
Oncogene; 1994 Mar; 9(3):911-21. PubMed ID: 8108135
[TBL] [Abstract][Full Text] [Related]
26. Constitutively active Gq-alpha stimulates prolactin promoter activity via a pathway involving Raf activity.
Tian J; Ma HW; Bancroft C
Mol Cell Endocrinol; 1995 Aug; 112(2):249-56. PubMed ID: 7489829
[TBL] [Abstract][Full Text] [Related]
27. Fibroblast growth factor receptor 4 is a target for the zinc-finger transcription factor Ikaros in the pituitary.
Yu S; Asa SL; Ezzat S
Mol Endocrinol; 2002 May; 16(5):1069-78. PubMed ID: 11981041
[TBL] [Abstract][Full Text] [Related]
28. Rapid phosphorylation of Ets-2 accompanies mitogen-activated protein kinase activation and the induction of heparin-binding epidermal growth factor gene expression by oncogenic Raf-1.
McCarthy SA; Chen D; Yang BS; Garcia Ramirez JJ; Cherwinski H; Chen XR; Klagsbrun M; Hauser CA; Ostrowski MC; McMahon M
Mol Cell Biol; 1997 May; 17(5):2401-12. PubMed ID: 9111309
[TBL] [Abstract][Full Text] [Related]
29. A role for the mitogen-activated protein kinase in mediating the ability of thyrotropin-releasing hormone to stimulate the prolactin promoter.
Wang YH; Maurer RA
Mol Endocrinol; 1999 Jul; 13(7):1094-104. PubMed ID: 10406461
[TBL] [Abstract][Full Text] [Related]
30. Regulation of the PRL promoter by Akt through cAMP response element binding protein.
Hayakawa J; Ohmichi M; Tasaka K; Kanda Y; Adachi K; Nishio Y; Hisamoto K; Mabuchi S; Hinuma S; Murata Y
Endocrinology; 2002 Jan; 143(1):13-22. PubMed ID: 11751586
[TBL] [Abstract][Full Text] [Related]
31. Differential regulation of pituitary-specific gene expression by insulin-like growth factor 1 in rat pituitary GH4C1 and GH3 cells.
Castillo AI; Aranda A
Endocrinology; 1997 Dec; 138(12):5442-51. PubMed ID: 9389530
[TBL] [Abstract][Full Text] [Related]
32. Involvement of a mitogen-activated protein kinase signaling pathway in the regulation of urokinase promoter activity by c-Ha-ras.
Lengyel E; Stepp E; Gum R; Boyd D
J Biol Chem; 1995 Sep; 270(39):23007-12. PubMed ID: 7559439
[TBL] [Abstract][Full Text] [Related]
33. The activity of the Ets transcription factor PEA3 is regulated by two distinct MAPK cascades.
O'Hagan RC; Tozer RG; Symons M; McCormick F; Hassell JA
Oncogene; 1996 Sep; 13(6):1323-33. PubMed ID: 8808707
[TBL] [Abstract][Full Text] [Related]
34. Cross-cascade activation of ERKs and ternary complex factors by Rho family proteins.
Frost JA; Steen H; Shapiro P; Lewis T; Ahn N; Shaw PE; Cobb MH
EMBO J; 1997 Nov; 16(21):6426-38. PubMed ID: 9351825
[TBL] [Abstract][Full Text] [Related]
35. Cyclic adenosine 3',5'-monophosphate activation of the rat prolactin promoter is restricted to the pituitary-specific cell type.
Keech CA; Jackson SM; Siddiqui SK; Ocran KW; Gutierrez-Hartmann A
Mol Endocrinol; 1992 Dec; 6(12):2059-70. PubMed ID: 1337142
[TBL] [Abstract][Full Text] [Related]
36. Prolactin-releasing peptide activation of the prolactin promoter is differentially mediated by extracellular signal-regulated protein kinase and c-Jun N-terminal protein kinase.
Kimura A; Ohmichi M; Tasaka K; Kanda Y; Ikegami H; Hayakawa J; Hisamoto K; Morishige K; Hinuma S; Kurachi H; Murata Y
J Biol Chem; 2000 Feb; 275(5):3667-74. PubMed ID: 10652364
[TBL] [Abstract][Full Text] [Related]
37. Hepatocyte growth factor/scatter factor activates the ETS1 transcription factor by a RAS-RAF-MEK-ERK signaling pathway.
Paumelle R; Tulasne D; Kherrouche Z; Plaza S; Leroy C; Reveneau S; Vandenbunder B; Fafeur V
Oncogene; 2002 Apr; 21(15):2309-19. PubMed ID: 11948414
[TBL] [Abstract][Full Text] [Related]
38. Cooperation of two PEA3/AP1 sites in uPA gene induction by TPA and FGF-2.
D'Orazio D; Besser D; Marksitzer R; Kunz C; Hume DA; Kiefer B; Nagamine Y
Gene; 1997 Nov; 201(1-2):179-87. PubMed ID: 9409785
[TBL] [Abstract][Full Text] [Related]
39. The ras and protein kinase A pathways are mutually antagonistic in regulating rat prolactin promoter activity.
Conrad KE; Gutierrez-Hartmann A
Oncogene; 1992 Jul; 7(7):1279-86. PubMed ID: 1620544
[TBL] [Abstract][Full Text] [Related]
40. Reconstitution of the protein kinase A response of the rat prolactin promoter: differential effects of distinct Pit-1 isoforms and functional interaction with Oct-1.
Diamond SE; Chiono M; Gutierrez-Hartmann A
Mol Endocrinol; 1999 Feb; 13(2):228-38. PubMed ID: 9973253
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
